Yoshichika Arakawa
- Molecular Medicine top 0.02%
- Antibiotic Resistance in Bacteria 123
- Endocrinology top 0.05%
- Microbiology top 0.2%
- Pollution top 0.5%
- Pharmaceutical and Antibiotic Environmental Impacts 33
-
- Pneumonia and Respiratory Infections 38
- Pneumocystis jirovecii pneumonia detection and treatment 22
-
- Streptococcal Infections and Treatments 37
- Neonatal and Maternal Infections 26
-
- Antibiotics Pharmacokinetics and Efficacy 31
-
- Bacterial biofilms and quorum sensing 26
- Co-authors
- Keigo ShibayamaJun‐ichi WachinoNaohiro ShibataKunikazu YamaneYohei DoiKouji KimuraHiroshi KurokawaSatowa Suzuki
- Journals
- The Lancet (1 paper)Journal of Biological Chemistry (1 paper)Angewandte Chemie International Edition (1 paper)
- Partner nations
- JapanUnited StatesSouth Korea
In The Last Decade
Yoshichika Arakawa
242 papers receiving 8.6k citations
Peers
Comparison fields: 5 of 132
- Molecular Medicine 5.3k
- Endocrinology 2.3k
- Applied Microbiology and Biotechnology 460
- Microbiology 958
- Pollution 1.3k
Countries citing papers authored by Yoshichika Arakawa
This map shows the geographic impact of Yoshichika Arakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshichika Arakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshichika Arakawa more than expected).
Fields of papers citing papers by Yoshichika Arakawa
This network shows the impact of papers produced by Yoshichika Arakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshichika Arakawa. The network helps show where Yoshichika Arakawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yoshichika Arakawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2018 | 15 | |
| 3 | 2018 | 8 | |
| 4 | 2013 | 53 | |
| 5 | 2013 | 8 | |
| 6 | 2012 | 1 | |
| 7 | 2011 | 7 | |
| 8 | 2009 | 3 | |
| 9 | 2009 | 39 | |
| 10 | 2008 | 17 | |
| 11 | 2007 | 21 | |
| 12 | 2006 | 41 | |
| 13 | 2006 | 11 | |
| 14 | 2006 | 25 | |
| 15 | 2006 | 3 | |
| 16 | 2004 | 0 | |
| 17 | 2003 | 3 | |
| 18 | 2002 | 5 | |
| 19 | A report of ceftazidime-resistant Klebsiella pneumoniae. | 1995 | 1 |
| 20 | 1994 | 1 |
About Yoshichika Arakawa
Yoshichika Arakawa is a scholar working on Molecular Medicine, Endocrinology and Microbiology, having authored 247 papers that have together received 8.9k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (123 papers), Pneumonia and Respiratory Infections (38 papers), Streptococcal Infections and Treatments (37 papers), Pharmaceutical and Antibiotic Environmental Impacts (33 papers), Antibiotics Pharmacokinetics and Efficacy (31 papers), Bacterial biofilms and quorum sensing (26 papers), Neonatal and Maternal Infections (26 papers) and Pneumocystis jirovecii pneumonia detection and treatment (22 papers). The work is most often cited by research in Molecular Medicine (5.3k citations), Endocrinology (2.3k citations) and Applied Microbiology and Biotechnology (460 citations). Yoshichika Arakawa has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Keigo Shibayama, Jun‐ichi Wachino, Naohiro Shibata, Kunikazu Yamane, Yohei Doi, Kouji Kimura, Hiroshi Kurokawa, Satowa Suzuki, Tetsuya Yagi and Haru Kato. Their work appears in journals such as The Lancet, Journal of Biological Chemistry and Angewandte Chemie International Edition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.